
Release date: 2026-04-02 15:53:30 Article From: Lucius Laos Recommended: 20
Belumosudil tablets should be swallowed whole with a full glass of water. Under no circumstances should they be split, crushed, or chewed, as this may impair efficacy or cause unnecessary adverse reactions.
If a dose is missed and remembered on the same day, take it as soon as possible. Then resume the regular dosing schedule the following day at the usual time. Do not take a double or extra dose to make up for the missed one. In case of accidental overdose, contact a healthcare provider immediately or go to the nearest hospital emergency department for medical assistance to ensure safety.
Belumosudil is a prescription medicine indicated for the treatment of chronic graft-versus-host disease (cGVHD) in adults and adolescents aged 12 years and older. Specifically, it is intended for patients who have failed at least two prior systemic therapies.
The safety and efficacy of belumosudil in children under 12 years of age have not been established.
The recommended dosage is once daily with food, taken at approximately the same time each day to maintain stable drug concentrations in the body. This helps maximize therapeutic efficacy and reduce risks associated with inconsistent dosing.
Proper storage is essential to maintain drug effectiveness.
Belumosudil should be stored at room temperature between 68°F and 77°F (20°C–25°C) in its original container to protect against moisture. Replace the cap tightly after each use and do not discard the desiccant packet inside the bottle.
Before starting treatment, disclose your full medical history to your doctor or pharmacist, especially any kidney or liver disorders. You must also provide a complete list of all medications you are taking, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements, as concomitant medications may interact with belumosudil and affect its efficacy, and vice versa.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:2172025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:4502024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended:2242025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended:2392025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended:2172025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended:2462025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended:2292025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended:2142025-27-11

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: